Interanimal variability in preexisting collaterals is a major factor determining outcome in experimental angiogenesis trials
Authors:
- Stephan ZbindenSZStephan Zbinden
- Leonardo C. ClavijoLCLeonardo C. Clavijo
- Birgit KantorBKBirgit Kantor
- Hakim MorsliHMHakim Morsli
- Guillermo A. CortesGCGuillermo A. Cortes
- James A. AndrewsJAJames A. Andrews
- Gil Jin JangGJGil Jin Jang
- Mary Susan BurnettMBMary Susan Burnett
- Stephen E. EpsteinSEStephen E. Epstein
- 1 April 2007
- journal article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 292 (4) , H1891-H1897
Abstract
Despite numerous animal trials reporting that cell therapy promotes collateral flow, clinical trials have not convincingly shown benefit. Patient-related risk factors are often used to explain these discrepancies. However, during the course of our own angiogenesis studies using mice, we noted large anatomical variability in collateral vessels. The purpose of the present investigation was to define how important this factor might be in determining intervention outcomes. Hindlimb ischemia was induced in BALB/c mice by ligating the superficial femoral artery. After 24 h, animals were treated by injecting the adductor muscle with either control media or cultured mesenchymal stem cells (MSCs). Blood flow recovery was measured using laser-Doppler [laser-Doppler perfusion imaging (LDPI) ratio]. In a second experiment, mice were stratified 24 h after arterial ligation before treatment by using a simple clinical score of the ligated leg: 1, able to flex, mild discoloration; 2, no flexion, mild discoloration; 3, severe discoloration; and 4, any necrosis. Without stratification, blood flow recovery significantly increased in the MSC-treated group (P < 0.05, n = 6 MSC group, n = 7 media group). In the experiment employing stratification, all differences between the groups disappeared (n = 11 MSC group, n = 10 media group; P = 0.3). Furthermore, we found a striking inverse correlation between clinical score on day 1 and the LDPI ratio on day 28 (P < 0.0001; n = 79). Anatomical confirmation of the disparity in preexisting collaterals was found in two different mouse strains using microscopic computed tomography. In conclusion, there is substantial interanimal variability in preexisting collateral flow, and this variability can importantly influence outcome. To overcome this, either animals must be stratified before treatment, the number of animals must be increased substantially, or, preferably, both.Keywords
This publication has 13 references indexed in Scilit:
- Delayed Arteriogenesis in Hypercholesterolemic MiceCirculation, 2005
- Profoundly Reduced Neovascularization Capacity of Bone Marrow Mononuclear Cells Derived From Patients With Chronic Ischemic Heart DiseaseCirculation, 2004
- Local Delivery of Marrow-Derived Stromal Cells Augments Collateral Perfusion Through Paracrine MechanismsCirculation, 2004
- Marrow-Derived Stromal Cells Express Genes Encoding a Broad Spectrum of Arteriogenic Cytokines and Promote In Vitro and In Vivo Arteriogenesis Through Paracrine MechanismsCirculation Research, 2004
- Secretion of Angiogenic and Antiapoptotic Factors by Human Adipose Stromal CellsCirculation, 2004
- Plasticity of Human Adipose Lineage Cells Toward Endothelial CellsCirculation, 2004
- Relevance of Monocytic Features for Neovascularization Capacity of Circulating Endothelial Progenitor CellsCirculation, 2003
- CD117+ stem cells play a key role in therapeutic angiogenesis induced by bone marrow cell implantationAmerican Journal of Physiology-Heart and Circulatory Physiology, 2003
- Blood-derived angioblasts accelerate blood-flow restoration in diabetic miceJournal of Clinical Investigation, 2000
- Transplanted cord blood–derived endothelial precursor cells augment postnatal neovascularizationJournal of Clinical Investigation, 2000